L-type Ca^2+^ channels are key actors in the various scenes that lead to cardiac contractility ([@bib68]; [@bib4]; [@bib5]). Their activation during the cardiac action potential allows Ca^2+^ to enter myocytes ([@bib4]; [@bib66]). This Ca^2+^ influx during systole results in an increase in myoplasmic Ca^2+^ concentration that leads to the activation of Ca^2+^ release channels known as ryanodine receptor 2 (RYR2) channels ([@bib61]; [@bib31]). RYR2s are mainly located in the terminal cisternae of the SR ([@bib71]; [@bib32]; [@bib45]). An increase in the open probability (Po) of RYR2 promotes Ca^2+^ release from the SR by a mechanism known as CICR ([@bib16]; [@bib20]; [@bib19]). Ultimately, this large increase in myoplasmic Ca^2+^ concentration results in cellular contraction. In this issue of *JGP*, Morales et al. investigate the mechanisms involved in regulating Ca^2+^ influx during sympathetic stimulation and, in particular, the role of Ca^2+^-dependent inactivation.

It has been known for more than 60 years that the autonomic nervous system modulates cardiac contractility ([@bib47]; [@bib37]; [@bib51]; [@bib9]; [@bib29]). In fact, the sympathetic nervous system increases contractility by releasing the catecholamines epinephrine and norepinephrine, which induce a positive ionotropic response ([@bib47]; [@bib18]; [@bib53]). When catecholamines bind to β-adrenergic receptors, they promote dissociation of a stimulatory G-protein α~s~ subunit and subsequent activation of adenyl cyclase ([@bib30]; [@bib6]). This activation increases the intracellular concentration of cAMP, which promotes dissociation of the catalytic subunit of PKA ([@bib42]; [@bib28]) and phosphorylation of multiple intracellular targets in the myocyte ([@bib10]; [@bib6]; [@bib58]; [@bib75]; [@bib78]; [Fig. 1 C](#fig1){ref-type="fig"}).

![**Overview of the molecular regulation of L-type Ca^2+^ currents. (A)** The central molecular components of a Ca~V~1.2 channel. The pore-forming subunit α~1~ and the regulatory subunits α~2~, δ, and Ca~V~ β. The interaction of Ca~V~ β and the N terminus of α~1~ are essential in defining the VDI. On the other hand, CaM binding site at the IQ motif located at the C terminaus is the protein locus involved in CDI. Interestingly, the PKA phosphorylation sites (S-1700 and S-1928) are also located at the C terminus. **(B)** The activation and inactivation of a numerically simulated L-type Ca^2+^ current. **(C)** The norepinephrine (NE) activation of the G-protein coupled receptor complex that finally leads to PKA phosphorylation of α~1~. The scheme illustrates that when α~1~ is phosphorylated, there will be an increase in the Ca^2+^ current that will promote a local increase in the free Ca^2+^ concentration on the cytosolic face of the channel. This elevation in Ca^2+^ concentration will increase the probability of binding between Ca^2+^ and CaM, a critical event that promotes CDI. **(D)** Upon PKA phosphorylation of the α~1~ subunit, there will be an increase both in the amplitude of the current and in the rate of CDI.](JGP_201912338_Fig1){#fig1}

There are two critical proteins that increase cardiac contractility when phosphorylated. One is phospholamban; a protein that, under basal conditions, inhibits the SERCA2-mediated uptake of Ca^2+^ into the SR ([@bib10]; [@bib50]; [@bib79]). Following adrenergic stimulation, phosphorylation of phospholamban at serine 16 by PKA ([@bib8]) and at threonine 17 by CAMKII ([@bib70]) relieves its inhibitory effect on SERCA2. The relief of this inhibition increases the rate of Ca^2+^ transport from the cytosol to the SR, thus increasing the Ca^2+^ content of the SR.

A second protein that induces a positive inotropic effect when phosphorylated by PKA is the L-type Ca^2+^ channel (Ca~V~1.2), which can be phosphorylated at two sites in the C terminus of the α~1~ subunit. One site is serine 1928 ([@bib13]; [@bib55]; [@bib24]; [@bib59]), located in the distal C terminus. The other site is serine 1700 ([@bib27]), located in the proximal C terminus ([Fig. 1, A and C](#fig1){ref-type="fig"}). However, the sites for PKA phosphorylation are still under discussion.

Interestingly, β subunits can be also phosphorylated. However, because α~1~1.2 can interact with different β subunits, all of which are phosphorylated in different ways, it is unclear if PKA phosphorylation of β subunits has a major role in L-type Ca^2+^ channel function ([@bib54]; [@bib82]).

In any event, PKA phosphorylation of L-type Ca^2+^ channels increases their Po ([@bib46]; [@bib3]; [@bib6]; [@bib74]). This increase in Po results from a change in the modal gating of Ca~V~1.2 ([@bib83]; [@bib14]; [@bib72]). Under voltage-clamp conditions, the increase in Po can be as large as three times ([@bib83]). Therefore, the myocyte needs to have a mechanism that limits an excessive influx of Ca^2+^ upon phosphorylation.

There are two negative feedback mechanisms that can limit the positive inotropic actions of catecholamines. Specifically, Ca~V~1.2 can reduce its own Po by two different inactivation mechanisms; voltage-dependent inactivation (VDI; [@bib11]; [@bib35]; [@bib49]; [@bib84]; [@bib21], [@bib22]) and Ca^2+^-dependent inactivation (CDI; [@bib77]; [@bib52]; [@bib44]; [@bib63]). These inactivation mechanisms not only have physiological importance, but are also critical in preventing pathological events during catecholaminergic stimulation ([@bib85]). For example, in the absence of these mechanisms, excessive Ca^2+^ influx leads to SR Ca^2+^ overload in myocytes. This overload increases the probability of spontaneous SR Ca^2+^ release events during diastole. Thus, β-adrenergic stimulation can induce delayed diastolic depolarizations, which can trigger extrasystolic action potentials and eventually ventricular tachycardias and arrhythmias ([@bib36]; [@bib12]; [@bib39]).

VDI is mediated by the interaction between the pore-forming Ca~V~ α~1~ subunit and Ca~V~ β subunits ([@bib67]; [@bib81]; [@bib41]; [@bib33]; [Fig. 1, A and C](#fig1){ref-type="fig"}). On the other hand, CDI is primarily mediated by the Ca^2+^ sensor calmodulin (CaM; [@bib86]; [@bib63]; [@bib64]). CaM has four helix-loop-helix domains (EF-hands) grouped within two lobes with low and high affinity for Ca^2+^ ([@bib7]). There is a Ca^2+^-dependent CaM-binding sequence, the IQ motif, in the cytoplasmic C-terminal tail of the channel's α~1~ subunit, which is critical for CDI ([@bib62]; [@bib65]; [@bib86]; [Fig. 1, A and C](#fig1){ref-type="fig"}). Although both inactivation mechanisms are physiologically relevant, there has been controversy about which of the two mechanisms have the larger impact on Ca~V~1.2 inactivation during the cardiac action potential ([@bib23]; [@bib25]). Moreover, a phenomenon that is even less understood is what happens with the L-type channel inactivation during adrenergic stimulation ([@bib57]; [@bib43]).

In the current issue of *JGP*, [@bib56] use a novel conjunction of molecular biology, electrophysiological approaches, and mathematical modeling to investigate the mechanisms involved in controlling Ca^2+^ influx during catecholaminergic stimulation. Specifically, the authors test the hypothesis that CDI is the central mechanism limiting adrenergic stimulation of L-type Ca^2+^ current. This hypothesis, presented in [Fig. 1](#fig1){ref-type="fig"}, postulates that Ca^2+^ ions permeating through L-type Ca^2+^ channels will locally increase the cytosolic Ca^2+^ concentration and induce a certain degree of CDI in the absence of a sympathetic stimulus ([Fig. 1, A and B](#fig1){ref-type="fig"}). However, in the presence of a catecholaminergic stimulus, there will be an increase in current permeating through the Ca^2+^ channels due to an increase in Ca~V~1.2 Po. This increase in Ca^2+^ current will not only augment Ca^2+^ influx into the myocyte, but also will increase the local cytosolic Ca^2+^ concentration. This local increase in Ca^2+^ will promote more CaM binding to Ca^2+^, leading to an increase in CDI. Thus, catecholaminergic stimulation will lead to an increase the amplitude of the Ca^2+^ current and also accelerate the rate of inactivation of the channel ([Fig. 1, B and D](#fig1){ref-type="fig"}).

In their paper, [@bib56] explore the role of VDI by overexpressing the Ca~V~ β~2~a subunit, known to dramatically slow down VDI ([@bib67]; [@bib81]). In a different set of experiments, the authors explore the relevance of CDI by inducing the expression of a mutated calmodulin (CaM~34~), known to abolish CDI ([@bib48]). The role of Ca~V~ β~2~a and/or the action of CaM34 are evaluated in experiments performed in neonatal cardiomyocytes. Specifically, myocytes were voltage clamped using the waveform of a self-action potential (sAP-Clamp; [@bib1], [@bib2]), recorded from the same cell in control and isoproterenol-treated conditions.

In control cells, the authors show very nicely that application of 100 nM isoproterenol shortens the action potential by increasing the rate of inactivation of the L-type Ca^2+^ current recorded with sAP-Clamp (Figs. 1 and 2 in [@bib56]). This suggests that modifying the rate of inactivation of the L-type current has a critical effect on the duration of the action potential. Additionally, in experiments performed in the absence of isoproterenol, the authors demonstrate that molecular interventions that alter the rate of inactivation of L-type Ca^2+^ channels dramatically prolong the duration of the action potential and Ca^2+^ currents. The expression of CaM~34~ increases action potential duration by more than five times (Fig. 5 in [@bib56]), and overexpression of CaV β~2~a increases action potential duration by more than three times (Fig. 6 in [@bib56]). These results confirm that the rate of inactivation of L-type Ca^2+^ currents defines the duration of the action potential in neonatal rat myocytes.

Figs. 8 and 9 in [@bib56] show the conclusive experiment designed to evaluate which of the L-type Ca^2+^ current inactivation mechanisms is dominant. The results presented in Fig. 8 illustrate that, in the absence of CDI induced by overexpression of CaM~34~, isoproterenol has a significantly smaller effect than when VDI is impaired by the expression of Ca~V~ β~2~a. This, along with isoproterenol's significantly larger effect in myocytes when CDI is not altered (Fig. 9), clearly indicates that CDI is the main mechanism for L-type Ca^2+^ channel inactivation during adrenergic stimulation.

As previously stated, these experiments were conducted in neonatal rat cardiomyocytes, a model that significantly differs from adult ventricular myocytes ([@bib17]; [@bib60]; [@bib73]). For example, neonatal myocytes have a reduced expression of Kv 4.X channels ([@bib38]; [@bib80]; [@bib40]) and the regulatory subunit KChIP ([@bib40]; [@bib34]). These K^+^ channels define a transient K^+^ outward current (Ito; [@bib26]; [@bib76]; [@bib69]) that can reshape action potential repolarization. Thus, because of the presence of Ito, we can expect that both VDI and CDI will have a smaller effect on action potential duration in adult myocytes.

Previous studies have also shown that CICR is not critical for defining intracellular Ca^2+^ dynamics during excitation--contraction coupling in neonatal cardiac myocytes ([@bib17]), primarily because the tubular system is not fully developed ([@bib15]). This reduced SR Ca^2+^ release in neonatal myocytes further supports the hypothesis presented by [@bib56]: Ca^2+^ release from the SR would likely augment the effect of CDI ([@bib44]). Indeed, SR Ca^2+^ release is dramatically increased during adrenergic stimulation, not only due to a larger triggering signal, but also because the intra SR Ca^2+^ content is higher. The increase in luminal SR Ca^2+^ content is mediated by an increase in Ca^2+^ influx into the myocyte during each action potential. In addition, SR Ca^2+^ content is further elevated due to phosphorylation of phospholamban, which in turn increases the SERCA2 transport rate. These findings suggest that the mechanism proposed by [@bib56] will be even more relevant in controlling Ca^2+^ influx during β−adrenergic stimulation in an adult heart.

In summary, [@bib56] use a novel and powerful approach to shed light upon a fundamental physiological and pathophysiological puzzle: how to prevent Ca^2+^ overload, and the pathological consequences of this overload, during a "fight or flight" response.
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